• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Pulmonary hypertension in scleroderma: about 12 cases].

作者信息

Diao Maboury, Ndiaye Mouhamadou Bamba, Kane Adama, Bodian Malick, Tchintchui Nadége Christelle, Mbaye Alassane, Mounir Dia Mouhamadoul, Sarr Moustapha, Kane Assane, Abdou Ba Serigne

机构信息

Hôpital Aristide Le Dantec, avenue Pasteur, Dakar, Sénégal.

出版信息

Pan Afr Med J. 2012;11:9. Epub 2012 Jan 18.

PMID:22368752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3283014/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/fa8166dba52b/PAMJ-11-09-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/39486af6fe5a/PAMJ-11-09-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/bab1b01cb312/PAMJ-11-09-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/316ca1831e0f/PAMJ-11-09-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/c9c053f3f291/PAMJ-11-09-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/fa8166dba52b/PAMJ-11-09-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/39486af6fe5a/PAMJ-11-09-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/bab1b01cb312/PAMJ-11-09-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/316ca1831e0f/PAMJ-11-09-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/c9c053f3f291/PAMJ-11-09-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a403/3283014/fa8166dba52b/PAMJ-11-09-g005.jpg

相似文献

1
[Pulmonary hypertension in scleroderma: about 12 cases].[硬皮病中的肺动脉高压：约12例]
Pan Afr Med J. 2012;11:9. Epub 2012 Jan 18.
2
Exercise-induced pulmonary hypertension in systemic sclerosis: a multifactorial entity.
Am Heart J. 2013 Sep;166(3):e13. doi: 10.1016/j.ahj.2013.06.014. Epub 2013 Jul 19.
3
Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension.伊伐布雷定用于治疗合并肺动脉高压的系统性硬化症安全且耐受性良好。
Clin Res Cardiol. 2012 Jul;101(7):593-4. doi: 10.1007/s00392-012-0437-1. Epub 2012 Mar 2.
4
[Pulmonary hypertension and systemic sclerosis].
G Ital Cardiol. 1993 Sep;23(9):871-6.
5
Response to letter to the editor by Rui Baptista, M.D., Rogério Teixeira, M.D.对医学博士鲁伊·巴普蒂斯塔和医学博士罗热里奥·特谢拉致编辑信的回复
Am Heart J. 2013 Sep;166(3):e15-6. doi: 10.1016/j.ahj.2013.06.015. Epub 2013 Jul 19.
6
Right ventricular longitudinal strain is diminished in systemic sclerosis compared with idiopathic pulmonary arterial hypertension.与特发性肺动脉高压相比，系统性硬化症患者的右心室纵向应变降低。
Eur Respir J. 2017 Nov 22;50(5). doi: 10.1183/13993003.01436-2017. Print 2017 Nov.
7
Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study.系统性硬皮病患者运动诱导性肺动脉高压的临床和超声心动图相关性：一项多中心研究。
Am Heart J. 2013 Feb;165(2):200-7. doi: 10.1016/j.ahj.2012.10.020. Epub 2012 Nov 28.
8
[The clinico-functional characteristics of pulmonary arterial hypertension in systemic scleroderma].[系统性硬化症中肺动脉高压的临床功能特征]
Ter Arkh. 1994;66(3):67-71.
9
Pulmonary hypertension and exercise echocardiography.肺动脉高压与运动超声心动图
Eur J Echocardiogr. 2006 Aug;7(4):261-2; author reply 263. doi: 10.1016/j.euje.2006.03.012. Epub 2006 Jun 8.
10
Right ventricular systolic pressure assessed by echocardiography: a predictive factor of mortality in patients with scleroderma.超声心动图评估右心室收缩压：硬皮病患者死亡率的预测因素。
Clin Cardiol. 2011 Aug;34(8):488-93. doi: 10.1002/clc.20920. Epub 2011 Jun 29.

引用本文的文献

1
Systemic sclerosis in sub-Saharan Africa: a systematic review.撒哈拉以南非洲的系统性硬化症：系统评价。
Pan Afr Med J. 2020 Oct 22;37:176. doi: 10.11604/pamj.2020.37.176.22557. eCollection 2020.
2
[Connective tissue diseases in the hospital setting in Lomé: a retrospective study of 231 cases].[洛美医院环境中的结缔组织病：231例回顾性研究]
Pan Afr Med J. 2018 Jun 26;30:176. doi: 10.11604/pamj.2018.30.176.14565. eCollection 2018.

本文引用的文献

1
Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study.系统性硬化症患者的死亡风险因素及3年生存率：法国ItinérAIR-Sclérodermie研究
Rheumatology (Oxford). 2009 Mar;48(3):304-8. doi: 10.1093/rheumatology/ken488. Epub 2009 Jan 27.
2
Pulmonary arterial hypertension associated to connective tissue diseases.与结缔组织病相关的肺动脉高压。
Lupus. 2005;14(9):713-7. doi: 10.1191/0961203305lu2206oa.
3
Cellular and molecular pathobiology of pulmonary arterial hypertension.
肺动脉高压的细胞与分子病理生物学
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):13S-24S. doi: 10.1016/j.jacc.2004.02.029.
4
Age and risk of pulmonary arterial hypertension in scleroderma.硬皮病患者的年龄与肺动脉高压风险
Chest. 2003 Dec;124(6):2098-104. doi: 10.1378/chest.124.6.2098.
5
[Pulmonary hypertension associated with connective tissue diseases].[与结缔组织病相关的肺动脉高压]
Rev Med Interne. 2002 Jan;23(1):41-54. doi: 10.1016/s0248-8663(01)00514-8.
6
[Pulmonary hypertension screening in systemic scleroderma: a cohort study of 67 patients].
Rev Med Interne. 2001 Sep;22(9):819-29. doi: 10.1016/s0248-8663(01)00433-7.
7
Recommendations on the management of pulmonary hypertension in clinical practice.临床实践中肺动脉高压管理的推荐意见。
Heart. 2001 Sep;86 Suppl 1(Suppl 1):I1-13.
8
Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival.系统性硬化症中的肺动脉高压：疾病进展的危险因素及对生存的影响
Rheumatology (Oxford). 2001 Apr;40(4):453-9. doi: 10.1093/rheumatology/40.4.453.
9
Diversity of myocardial involvement in systemic sclerosis: an 8-year study of 95 Japanese patients.系统性硬化症中心肌受累的多样性：对95例日本患者的8年研究
Am Heart J. 1998 Jun;135(6 Pt 1):960-9. doi: 10.1016/s0002-8703(98)70060-2.
10
Prevalence of pulmonary hypertension in limited and diffuse scleroderma.
Chest. 1996 Dec;110(6):1515-9. doi: 10.1378/chest.110.6.1515.